Randomisation
A range of potential treatments have been suggested for COVID-19 but nobody knows if any of them will turn out to be more effective in helping people recover than the usual standard of hospital care which all patients will receive.
The RECOVERY Trial is currently testing these suggested treatments:
- baricitinib
- dimethyl fumarate
- high dose vs standard corticosteroids
- empagliflozin.
RECOVERY AND CO-ENROLMENT WITH OTHER TRIALS
online rANDOMISATION system
When you have done your training, please follow this link to the online randomisation system. If you do not know your site’s password, your site principal investigator can provide it.
Downloads
Please note, these are sample randomisation forms. Randomisation can only be carried out online.
RECOVERY randomisation form v17 (adult)
RECOVERY randomisation form v17 (DMF)
RECOVERY randomisation form v17 (international)
RECOVERY randomisation form v17 (Nepal)
RECOVERY legal representative participant information sheet (PIS)
RECOVERY participant information sheet (PIS) + consent form (adults)
RECOVERY participant information sheet (PIS) + consent form (children)
translations
RECOVERY participant information sheet and consent form - Bengali
RECOVERY participant information sheet and consent form - French
RECOVERY participant information sheet and consent form - Polish
RECOVERY participant information sheet and consent form - Portuguese
RECOVERY participant information sheet and consent form - Punjabi
RECOVERY participant information sheet and consent form - Urdu
RECOVERY participant information sheet and consent form - Welsh
Acknowledgements to:
Health and Care Research Wales,
London Metropolitan University,
The Guildhall School of Business and Law and their network of translators,
The NIHR Clinical Research Network.